Fan Zhen business area

Biopharmaceutical manufacturing fan Zhen based on materials for disclosure of business explain it back as follows.

 

Fan Zhen's bio-pharmaceutical industry

 

Drugs are usually chemical synthetic drugs can be separated into bio-pharmaceuticals, biotechnology drugs stems from the person or creature that the raw materials or ingredients that are manufactured by recombinant DNA medicines as pharmaceutical formulation, in biology, cell culture, cell Therapeutics, gene Therapeutics.

The development of a new working mechanism of chemical synthetic drugs has made it difficult to spend vast amounts of research and development of innovative drug development in relation to either the rain gradually improved, and the traditional blockbuster drugs expire in accordance with the patent of the increasingly competitive development of the product (generic) easier to copy the price declines in the market growth, such as difficulty, while Bio-medicines have been developed based on technology and biotechnology are present in particular in vivo protein targeting to be effective and have less side effects from medicines developed recombinant DNA technology in the 1980s, as dramatically as a result of the disease, such as insulin and growth hormone in the body, due to insufficient protein supplement to cure diseases by the first generation of biotech drugs have appeared for the first time was to

 

The first generation of biotech drugs are mainly used as bacterial, yeast, etc. produced by the host for insulin and growth hormone, and the second generation of bio-medicine is mainly produced using animal cells to treat as antibodies, fusion proteins, EPO, interferon, etc.

 

In recent years, in contrast to efficacy or ease of use, such as bio-pharmaceuticals increased modified bio-Baie (biobetter) for the development of the competition among manufacturers is underway, and the body than the original active sustainability and increased product is being sold on the market for some

Biopharmaceutical market

With a wide range of bio-medicine consists of the entire market, mainly protein therapeutics, antibody Therapeutics, vaccines, stem cell Therapeutics and gene Therapeutics, such as credit, but in this case, our main business-related protein therapeutics-oriented market-driven analysis of the original drugs.

 

Currently approved for sale during the full number of those products bio-pharmaceutical drugs are nothing more than about 3 percent, but accounted for roughly 20% of the total pharmaceutical market. In 2015, since the current sales of medicines on items over 50% of the top 100 bio-medicines is expected to take up global biopharmaceutical average growth rate is about 9 percent forecast, and bio-medicines are very high compared to synthetic drugs have the industrial added value, and therefore the future pharmaceutical market growth will be driven by bio-medicines.

In the pharmaceutical industry with emphasis and importance of bio-pharmaceuticals

. More fan Jenn to do business based on a bio-pharmaceutical industry disclosure material to the narrative